Overview Pharmacokinetic Study in Healthy Volunteers Status: Completed Trial end date: 2011-04-01 Target enrollment: Participant gender: Summary Phase 1 clinical trial to evaluate insulin exposure using different formulations of Technosphere Insulin Inhalation Powder using the Gen2 inhaler in healthy normal volunteers. Phase: Phase 1 Details Lead Sponsor: Mannkind CorporationTreatments: InsulinInsulin, Globin Zinc